carbachol has been researched along with Granulocytic Leukemia, Chronic in 2 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aydın, B | 2 |
| Gören, MZ | 1 |
| Kanlı, Z | 1 |
| Cabadak, H | 2 |
| Kan, B | 1 |
2 other studies available for carbachol and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Cross-talk of cholinergic and β-adrenergic receptor signalling in chronic myeloid leukemia K562 cells.
Topics: Adrenergic beta-Antagonists; Apoptosis; Carbachol; Caspase 3; Cell Proliferation; Cholinergic Agents | 2022 |
Regulation of M2, M3, and M4 muscarinic receptor expression in K562 chronic myelogenous leukemic cells by carbachol.
Topics: Animals; Atropine; Blotting, Western; Carbachol; CHO Cells; Cricetinae; Cricetulus; Gene Expression | 2011 |